{"id":160,"date":"2019-09-13T17:22:21","date_gmt":"2019-09-13T17:22:21","guid":{"rendered":"https:\/\/ferriscan.com\/?page_id=160"},"modified":"2021-06-04T03:25:16","modified_gmt":"2021-06-04T03:25:16","slug":"why-choose-ferriscan","status":"publish","type":"page","link":"https:\/\/ferriscan.com\/why-choose-ferriscan\/","title":{"rendered":"FerriScan for Clinicians"},"content":{"rendered":"\t\t
FerriScan provides an accurate measurement of liver iron concentration (LIC) through a non-invasive, MRI-based technology. FerriScan was regulatory cleared by the FDA for the measurement of LIC in 2005. In January 2013 FerriScan gained an additional clearance from the FDA as a companion diagnostic to aid in the identification and monitoring of non-transfusion-dependent thalassemia patients receiving therapy with deferasirox. FerriScan is now internationally recongized as the gold standard in liver iron concentration (LIC) measurement.<\/p>
FerriScan has originally been validated against liver biopsy on several makes and models of MR scanner in hundreds of patients, and has high sensitivity and specificity for measuring LIC. FerriScan results are clinically validated to be unaffected by inflammation, fibrosis or cirrhosis. To date, FerriScan has been used for over 50,000 patient measurements at hundreds of MR centers worldwide. FerriScan has also now been used in many multi-national, multi-site clinical trials by pharmaceutical companies.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t FerriScan is reimbursed in all Canadian provinces as an ‘Out-of-Country Medical Service’. The treating clinician must forward an application for each patient to the province’s Ministry of Health (MOH) for approval. Once approved, the MOH will grant a timeframe for the patient to have their FerriScan and\/or Cardiac T2*.\u00a0<\/p> To help with the application process, we’ve compiled a list of resources that may help you with your prior approval submissions:<\/p>Advantages of FerriScan<\/span> over serum ferritin (SF)\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
Advantages of FerriScan<\/span> over liver biopsy\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t\t
Advantages of FerriScan<\/span> over Liver T2* (MRI)\n<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t
Comparison of Studies Conducted Using FerriScan and T2* MRI<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
Range of LIC Results Produced by Different T2* Calibrations<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
FerriScan Reimbursement<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
Canada<\/h5>
Ontario<\/h6>
British Columbia<\/h6>
Alberta<\/h6>
Manitoba<\/h6>
Saskatchewan<\/h6>
Quebec<\/h6>